Clearmind Medicine Inc. has announced that it will hold its annual general and special meeting of shareholders virtually on December 29, 2025. During the meeting, shareholders will consider and vote on several resolutions, including the presentation of audited financial statements, fixing the number of directors, election of directors, appointment of an auditor, and approval of an omnibus equity incentive plan. The meeting will also address any further business that may properly come before the shareholders.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Clearmind Medicine Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-116075), on November 28, 2025, and is solely responsible for the information contained therein.
Comments